These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 2837370)

  • 1. Diagnosis of malignant ascites. Comparison of ascitic fibronectin, cholesterol, and serum-ascites albumin difference.
    Prieto M; Gómez-Lechón MJ; Hoyos M; Castell JV; Carrasco D; Berenguer J
    Dig Dis Sci; 1988 Jul; 33(7):833-8. PubMed ID: 2837370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosing ascites: value of ascitic fluid total protein, albumin, cholesterol, their ratios, serum-ascites albumin and cholesterol gradient.
    Gupta R; Misra SP; Dwivedi M; Misra V; Kumar S; Gupta SC
    J Gastroenterol Hepatol; 1995; 10(3):295-9. PubMed ID: 7548806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ascitic fluid concentrations of fibronectin and cholesterol: comparison of differential diagnostic value with the conventional protein determination.
    Gerbes AL; Xie YN; Mezger J; Jüngst D
    Liver; 1990 Jun; 10(3):152-7. PubMed ID: 2385156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical value of tumour markers and serum-ascites albumin gradient in the diagnosis of malignancy-related ascites.
    Chen SJ; Wang SS; Lu CW; Chao Y; Lee FY; Lee SD; Wu SL; Cherng KL; Lo KJ
    J Gastroenterol Hepatol; 1994; 9(4):396-400. PubMed ID: 7948823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Concentration of lipids in ascitic fluid and the concentration gradient of albumin in blood and ascites: diagnostic significance].
    Barbare JC; Diab G; Delavenne J; Philippe JM; Vorhauer W; Latrive JP; Capron JP
    Ann Gastroenterol Hepatol (Paris); 1989 Nov; 25(6):251-6. PubMed ID: 2619252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of ascitic lipids in the differentiation between cirrhotic and malignant ascites.
    Jüngst D; Gerbes AL; Martin R; Paumgartner G
    Hepatology; 1986; 6(2):239-43. PubMed ID: 3957233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ascitic fluid alpha 1-antitrypsin.
    Villamil FG; Sorroche PB; Aziz HF; Lopez PM; Oyhamburu JM
    Dig Dis Sci; 1990 Sep; 35(9):1105-9. PubMed ID: 2167827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibronectin, cholesterol and triglycerides ascitic fluid concentration in the prediction of malignancy.
    Colloredo Mels G; Bellati G; Auriemma L; Perani C; Leandro G; Vacca N; Pinna N; Alfieri G; Ideo G
    Ital J Gastroenterol; 1991 May; 23(4):179-86. PubMed ID: 1661195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated ascitic fluid fibronectin concentration. A non-specific finding.
    Runyon BA
    J Hepatol; 1986; 3(2):219-22. PubMed ID: 3794302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of fibronectin as a marker of malignant ascites.
    Siddiqui RA; Kochhar R; Singh V; Rajwanshi A; Goenka MK; Mehta SK
    J Gastroenterol Hepatol; 1992; 7(2):161-4. PubMed ID: 1571498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignancy-related ascites: a diagnostic pitfall of spontaneous bacterial peritonitis by ascitic fluid polymorphonuclear cell count.
    Wang SS; Lu CW; Chao Y; Lee MY; Lin HC; Lee SD; Tsai YT; Chen CC; Lo KJ
    J Hepatol; 1994 Jan; 20(1):79-84. PubMed ID: 8201226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ascitic fluid analysis in peritoneal carcinomatosis: comparison of various biochemical tests with ascitic cirrhotics.
    Lu CW; Wang SS; Lee SD; Tsai YT; Lee FY; Shiesh SC; Wu SL; Lu RH; Lo KJ
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 May; 47(5):350-6. PubMed ID: 1649678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ascitic fluid analysis in malignancy-related ascites.
    Runyon BA; Hoefs JC; Morgan TR
    Hepatology; 1988; 8(5):1104-9. PubMed ID: 3417231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of ascitic fluid cholesterol as a marker for malignant ascites.
    Rana SV; Babu SG; Kocchar R
    Med Sci Monit; 2005 Mar; 11(3):CR136-42. PubMed ID: 15735567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ascitic fluid analysis in hepatocellular carcinoma.
    Colli A; Cocciolo M; Riva C; Marcassoli L; Pirola M; Di Gregorio P; Buccino G
    Cancer; 1993 Aug; 72(3):677-82. PubMed ID: 8392901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ascitic fluid: the value of various biological tests in the differential diagnosis between cirrhotic and neoplastic ascites].
    Ghilain JM; Henrion J; Schapira M; Majois F; Beauduin M; Heller FR
    Acta Gastroenterol Belg; 1990; 53(2):168-79. PubMed ID: 2267897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fibronectin in the ascitic fluid: its diagnostic significance].
    Mal F; Nizard G; Labadie H; Trinchet JC; Garnier M; Beaugrand M
    Gastroenterol Clin Biol; 1987 Oct; 11(10):639-42. PubMed ID: 2826281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of ascitic lipids and sero-ascitic gradient of albumin in the differential diagnosis of ascites].
    Cabral JE; Leitão MC; Guerra C; Tomé L; Pinto ML; Costa D; Monteiro G
    Acta Med Port; 1989; 2(1):17-20. PubMed ID: 2773676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total discrimination of peritoneal malignant ascites from cirrhosis- and hepatocarcinoma-associated ascites by assays of ascitic cholesterol and lactate dehydrogenase.
    Castaldo G; Oriani G; Cimino L; Topa M; Mostarda I; Castellano L; Del Vecchio-Blanco C; Budillon G; Salvatore F; Sacchetti L
    Clin Chem; 1994 Mar; 40(3):478-83. PubMed ID: 8131285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genesis of fibronectin in ascites--detection of cellular and plasma fibronectin in portal and malignant ascites].
    Rieder H; Ramadori G; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1991 Jan; 29(1):16-21. PubMed ID: 2058224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.